Among the explored prostate cancer cell markers are the prostate-specific membrane antigen (PSMA) and the gastrin-releasing peptide receptor (GRPR) [2], which are also expressed in other malignancies, including breast cancer [3,4]. Here, FOLH1 is linked to prostate carcinoma.